ADOLESCENT LUPUS NEPHRITIS
Clinical trials for ADOLESCENT LUPUS NEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new ADOLESCENT LUPUS NEPHRITIS trials appear
Sign up with your email to follow new studies for ADOLESCENT LUPUS NEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lupus kidney drug study in teens halted early
Disease control TerminatedThis study aimed to check the long-term safety of voclosporin, a drug for lupus nephritis, in adolescents and children. It planned to follow participants for up to 12 extra months after they finished a previous study. However, the study was stopped early and only enrolled 4 peopl…
Matched conditions: ADOLESCENT LUPUS NEPHRITIS
Phase: PHASE3 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 24, 2026 16:17 UTC
-
Kidney drug trial for young lupus patients halted early
Disease control TerminatedThis study tested whether adding the drug voclosporin to standard treatment could help control kidney inflammation in children and teenagers with lupus nephritis. Participants received either voclosporin or a placebo along with their usual medications for 24 weeks. The main goal …
Matched conditions: ADOLESCENT LUPUS NEPHRITIS
Phase: PHASE3 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC